Better decision making in preventive health screening: Balancing benefits and harms.
作者信息
Bell Neil R, Grad Roland, Dickinson James A, Singh Harminder, Moore Ainsley Elizabeth, Kasperavicius Danielle, Kretschmer Kaylyn L
机构信息
Professor in the Department of Family Medicine at the University of Alberta in Edmonton.
Associate Professor in the Department of Family Medicine at McGill University in Montreal, Que.
出版信息
Can Fam Physician. 2017 Jul;63(7):521-524.
Abstract
摘要
相似文献
1
Better decision making in preventive health screening: Balancing benefits and harms.
Can Fam Physician. 2017 Jul;63(7):521-524.
2
Colorectal cancer--to screen or not to screen?
HMO Pract. 1989 Jul-Aug;3(4):137-41.
3
Cancer Screening, Overdiagnosis, and Regulatory Capture.
JAMA Intern Med. 2017 Jul 1;177(7):915-916. doi: 10.1001/jamainternmed.2017.1198.
4
Endoscopist Specialty Predicts the Likelihood of Recommending Cessation of Colorectal Cancer Screening in Older Adults.
Am J Gastroenterol. 2018 Dec;113(12):1862-1871. doi: 10.1038/s41395-018-0406-z. Epub 2018 Nov 2.
5
A piece of my mind. Should C be a passing grade for the USPSTF?
JAMA. 2015 Feb 3;313(5):465-6. doi: 10.1001/jama.2014.17082.
6
Decision-making about mammographic screening: pursuing informed choice.
Climacteric. 2018 Jun;21(3):209-213. doi: 10.1080/13697137.2017.1406912. Epub 2018 Feb 8.
7
The American Medical Association Guidelines for Adolescent Preventive Services.
Arch Pediatr Adolesc Med. 1997 Sep;151(9):958-9. doi: 10.1001/archpedi.1997.02170460096021.
8
American Cancer Society Changes Breast Cancer Screening Guidelines To Reflect Analysis of Benefits and Harms.
J Natl Cancer Inst. 2016 Feb 9;108(2). doi: 10.1093/jnci/djw022. Print 2016 Feb.
9
U.S. Preventive Services Task Force Confronts Critics.
J Natl Cancer Inst. 2017 Sep 1;109(9). doi: 10.1093/jnci/djx204.
10
Detecting cancer in primary care: Where does early diagnosis stop and overdiagnosis begin?
Eur J Cancer Care (Engl). 2017 May;26(3). doi: 10.1111/ecc.12692. Epub 2017 Apr 20.
引用本文的文献
1
Discussing the potential consequences of a diagnostic label before routine non-cancer screening: qualitative study with general practitioners and consumers.
BJPsych Open. 2025 Jun 11;11(4):e106. doi: 10.1192/bjo.2025.5.
2
One-size-fits-all versus risk-category-based screening interval strategies for cardiovascular disease prevention in Chinese adults: a prospective cohort study.
Lancet Reg Health West Pac. 2024 Jul 16;49:101140. doi: 10.1016/j.lanwpc.2024.101140. eCollection 2024 Aug.
3
Response.
Can Fam Physician. 2024 May;70(5):296-297. doi: 10.46747/cfp.7005296_1.
4
Two-Year-Span Breast Cancer Screening Uptake in Japan after the COVID-19 Pandemic and Its Association with the COVID-19 Vaccination.
Cancers (Basel). 2024 May 5;16(9):1783. doi: 10.3390/cancers16091783.
5
Perinatal anxiety disorders screening study: a study protocol.
BMC Psychiatry. 2024 Feb 24;24(1):162. doi: 10.1186/s12888-024-05575-9.
6
Quantifying the psychological and behavioural consequences of a diagnostic label for non-cancer conditions: systematic review.
BJPsych Open. 2023 Apr 19;9(3):e73. doi: 10.1192/bjo.2023.49.
7
Does financial literacy influence preventive health check-up behavior in Japan? a cross-sectional study.
BMC Public Health. 2022 Sep 8;22(1):1704. doi: 10.1186/s12889-022-14079-8.
8
What should educators teach to improve preventive health care?
Can Fam Physician. 2022 Aug;68(8):583-588. doi: 10.46747/cfp.6808583.
9
[Not Available].
Can Fam Physician. 2022 Aug;68(8):e241-e247. doi: 10.46747/cfp.6808e241.
10
Evaluation of a Program to Screen Patients in Community Pharmacies for Opioid Misuse and Accidental Overdose.
Prev Chronic Dis. 2022 Jul 14;19:E41. doi: 10.5888/pcd19.220028.
本文引用的文献
1
Clinicians' Expectations of the Benefits and Harms of Treatments, Screening, and Tests: A Systematic Review.
JAMA Intern Med. 2017 Mar 1;177(3):407-419. doi: 10.1001/jamainternmed.2016.8254.
2
Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis.
N Engl J Med. 2016 Aug 18;375(7):614-7. doi: 10.1056/NEJMp1604412.
3
Recommendations on screening for lung cancer.
CMAJ. 2016 Apr 5;188(6):425-432. doi: 10.1503/cmaj.151421. Epub 2016 Mar 7.
4
Walking the tightrope: communicating overdiagnosis in modern healthcare.
BMJ. 2016 Feb 5;352:i348. doi: 10.1136/bmj.i348.
5
Recommendations on screening for cognitive impairment in older adults.
CMAJ. 2016 Jan 5;188(1):37-46. doi: 10.1503/cmaj.141165. Epub 2015 Nov 30.
6
Physicians and knowledge translation of statistics: Mind the gap.
CMAJ. 2016 Jan 5;188(1):11-12. doi: 10.1503/cmaj.151254. Epub 2015 Nov 30.
7
Do clinicians understand the size of treatment effects? A randomized survey across 8 countries.
CMAJ. 2016 Jan 5;188(1):25-32. doi: 10.1503/cmaj.150430. Epub 2015 Oct 26.
8
The challenge of overdiagnosis begins with its definition.
BMJ. 2015 Mar 4;350:h869. doi: 10.1136/bmj.h869.
9
Overdiagnosis in mammography screening: a 45 year journey from shadowy idea to acknowledged reality.
BMJ. 2015 Mar 3;350:h867. doi: 10.1136/bmj.h867.
10
Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods.
BMJ. 2015 Jan 7;350:g7773. doi: 10.1136/bmj.g7773.
Zotero 插件